Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Annals of Hepatology|December 17, 2009
Clinical and basal aspects of anemia during antiviral therapy for hepatitis CHanneke van Soest, Willem Renooij, Karel J van ErpecumJournal of Hepatology|July 5, 2012
Preventive versus "on-demand" nutritional support during antiviral treatment for hepatitis C: a randomized controlled trialEllen J Huisman, Bart van Hoek, Hanneke van Soest, et al.Journal of Pediatric Gastroenterology and Nutrition|July 31, 2008
Growth and final height after liver transplantation during childhoodRene Scheenstra, Willem Jan Gerver, Roelof J Odink, et al.Anesthesiology|April 29, 2004
Cerebral oxygen extraction and autoregulation during extracorporeal whole body hyperthermia in humansOlaf L Cremer, Jan C Diephuis, Hanneke van Soest, et al.Annals of Hepatology|September 14, 2011
Impact of Fibroscan on management of chronic viral hepatitis in clinical practiceDietje Fransen van de Putte, Renske Blom, Hanneke van Soest, et al.Clinics and Research in Hepatology and Gastroenterology|July 20, 2015
Effects of preventive versus "on-demand" nutritional support on paid labour productivity, physical exercise and performance status during PEG-interferon-containing treatment for hepatitis CEllen J Huisman, Suzanne van Meer, Bart van Hoek, et al.European Journal of Gastroenterology & Hepatology|August 24, 2010
Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatmentLotte G Van Vlerken, Hanneke Van Soest, Mart P Janssen, et al.European Journal of Gastroenterology & Hepatology|October 2, 2009
Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapyKarin F Kok, Hanneke van Soest, Antonius E van Herwaarden, et al.European Journal of Gastroenterology & Hepatology|December 11, 2024
Increase in prevalence and costs of cirrhosis in the Netherlands: a nationwide hospital diagnosis data analysisKoos de Wit, Diederick J van Doorn, Gwen M C Masclee, et al.Therapeutic Drug Monitoring|July 16, 2013
Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcomeLotte G van Vlerken, Clara T M M de Kanter, Greet J Boland, et al.Pageof 2